Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Free Report) is expected to be releasing its Q3 2026 results before the market opens on Tuesday, November 3rd. Analysts expect the company to post earnings of $0.6510 per share and revenue of $5.54 billion for the quarter. Investors can find conference call details on the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Tuesday, November 3, 2026 at 8:00 AM ET.
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Free Report) last issued its quarterly earnings data on Monday, August 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.62 by $0.04. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.83% and a return on equity of 9.28%. The company had revenue of $5.55 billion for the quarter, compared to the consensus estimate of $5.48 billion. On average, analysts expect Fresenius Medical Care AG & Co. KGaA to post $2.24 EPS for the current fiscal year and $2.31 EPS for the next fiscal year.
Fresenius Medical Care AG & Co. KGaA Price Performance
Shares of NYSE:FMS opened at $22.75 on Tuesday. The company has a 50-day simple moving average of $22.48 and a 200-day simple moving average of $22.89. Fresenius Medical Care AG & Co. KGaA has a one year low of $20.02 and a one year high of $27.40. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.75 and a current ratio of 1.07. The stock has a market capitalization of $12.22 billion, a price-to-earnings ratio of 11.78, a PEG ratio of 5.29 and a beta of 0.74.
Wall Street Analysts Forecast Growth
A number of research analysts have recently issued reports on FMS shares. Zacks Research lowered shares of Fresenius Medical Care AG & Co. KGaA from a “hold” rating to a “strong sell” rating in a research note on Thursday, October 15th. Berenberg Bank set a $24.00 price objective on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Tuesday, September 29th. Citigroup restated a “neutral” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research note on Friday, July 17th. Weiss Ratings raised Fresenius Medical Care AG & Co. KGaA from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, October 8th. Finally, Sanford C. Bernstein increased their price objective on Fresenius Medical Care AG & Co. KGaA from $25.50 to $25.80 and gave the stock a “market perform” rating in a research report on Thursday, August 6th. Seven investment analysts have rated the stock with a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Reduce” and a consensus target price of $23.42.
Read Our Latest Stock Report on Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA Company Profile
Fresenius Medical Care AG & Co KGaA is a Germany-based health care company focused on the treatment of chronic kidney failure. The company provides dialysis care for patients with end-stage renal disease through a network of outpatient dialysis clinics and other health care facilities.
In addition to operating dialysis centers, Fresenius Medical Care develops and supplies products used in dialysis treatment. Its portfolio includes hemodialysis machines, dialyzers, dialysis solutions, bloodlines, and related medical devices and services.
Read More
- Five stocks we like better than Fresenius Medical Care AG & Co. KGaA
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
